Article
Pfs47 as a Malaria Transmission-Blocking Vaccine Target
11 Jul 2022
Abstract excerpt
Transmission-blocking vaccines (TBVs), pioneered by Richard Carter and others, aim to prevent parasite development in the mosquito vector and are a promising new tool for malaria elimination. Pfs47, recently identified as a TBV target, is a three-domain 6-cysteine protein on the surface of Plasmodium falciparum sexual stages. Pfs47 allows the parasite to evade mosquito immunity and is key for P. falciparum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
